In this webinar, we’ll examine how pharma companies can use data and insights to make the most of this critical stage. We’ll discuss how targeted investments in Phase 2B/3 can provide an early look at access barriers throughout the patient journey.

In this BioPharma Dive webinar, Hannah Baxter, partner at The Dedham Group, and Steve Callahan, senior director of Advisory & Insights, MMIT, share insights from our 2025 State of Patient Access survey.

In this webinar, we’ll explain how MMIT, with NorstellaLinQ, developed a robust, unified dataset to provide comprehensive insights into a rare disease population.

In this webinar, learn how best practices for targeting and engaging physicians both in-person and via non-personal promotion techniques.

In the immediate post-launch timeframe, pharma companies can use market access research to improve coverage and utilization. In this webinar, our experts explain the benefits of everything from post-label indication research to competitor analyses and payer/IDN perception tracking.

In this webinar, MMIT’s Steve Callahan and AssistRx’s Brok Vandersteen discuss the payer, regulatory and market updates that will impact patient services’ financial assistance programs in 2025.

In this webinar, learn what kinds of market access research pharma companies should complete in the six to twelve months before launch to strengthen their performance.

In this BioPharma Dive webinar, Dinesh Kabaleeswaran, SVP of Consulting and Advisory Services at MMIT, and Jen Klarer, partner and head of Cell & Gene Therapy at The Dedham Group, explain the results of our 2024 State of Patient Access Survey.

This webinar details how and why manufacturers benefit from early market research, using client use cases to show how planning for potential access scenarios leads to greater utilization at launch.

To eliminate access barriers, manufacturers need more than the traditional coverage and restriction data. This webinar addresses how and why market access is broadening to include patient-level data and analytics.

In a recent BioPharma Dive webinar, three industry experts discussed how integrated RWD can help pharma companies understand and improve the patient treatment journey.

Whether new clinical results support your brand or a new competitor is challenging it, rapid turn-around market research can help enhance manufacturers’ understanding of key market events or unexpected changes in the market.